How can skeptics have a dialogue with homeopaths?

Question by Michelle: How can skeptics have a dialogue with homeopaths?
without pointing out the stupidity of their arguments? I’m thinking about the paranoid ramblings about big pharma as well as the ignorance of simple science.
Goodhealth surfing

No mate the question is fine as it is, can you answer it?

Best answer:

Answer by shad0wr4ven
There is no such thing as logical persuasive dialogue with paranoia.

Answer by dave
Crucially, homeopaths lack the educational level to understand how their potions can only be water. They also lack the education to understand the basics of statistical analysis and clinical trials. This also applies to anyone who posts on this forum supporting homeopathy.

In the VERY rare situation where you have an educated person such as a doctor pushing this quackery, they are aware it cannot work but as it’s a ready source of low risk, profitable and desirable (as in no yukky) work, then they know it’s just too much of a good earner to ignore.

In the first situation, dialogue is impossible as the homeopaths lack the educational level necessary to converse about the subject.

In the second situation, dialogue is avoided as they are aware it does not work and also aware that all they have to defend themselves is outright denial, which tends to make them look foolish in the eyes of any existing and prospective customers.

Pfizer's Deal on Generic Viagra Shows Treatment Changes
Fifteen years after Pfizer (PFE) Inc.'s Viagra changed the sexual equation for older men, the blockbuster impotence drug is set to become available in a less expensive generic form as early as 2017. Pfizer's little blue pill, which generally cost about … Read more on Bloomberg

Johnson & Johnson's Imbruvica Will Be a Costly Treatment
Imbruvica, a drug by Pharmacyclics Inc. (NYSE:PCYC) and Johnson & Johnson's (NYSE:JNJ) Janssen Biotech, Inc., has been approved by the Food and Drug Administration to treat patients with mantle cell lymphoma (MCL). The new drug comes at a high … Read more on Wall St. Cheat Sheet